Literature DB >> 20306213

Prolonged infections associated with antineutrophil cytoplasmic antibodies specific to proteinase 3 and myeloperoxidase: diagnostic and therapeutic challenge.

Branka Bonaci-Nikolic1, Sladjana Andrejevic, Milorad Pavlovic, Zoran Dimcic, Branislava Ivanovic, Milos Nikolic.   

Abstract

Chronic infections may mimic antineutrophil cytoplasmic antibody (ANCA)-associated vasculitides (AAV). We investigated which markers may help in the diagnosis and the prognosis of infections associated with proteinase 3 (PR3) and myeloperoxidase (MPO)-ANCA. In this study (1993-2008)--with an average follow-up of 5.1 years--we compared 66 AAV patients with 17 PR3 and/or MPO-ANCA-positive patients with protracted bacterial (11/17) or viral (6/17) infections. Seven of 17 patients had subacute bacterial endocarditis (SBE), while six of 17 patients had various autoimmune manifestations of chronic hepatitis C virus (HCV) infection. We determined ANCA, antinuclear antibodies, anti-PR3, anti-MPO, anticardiolipin (aCL), antibeta 2 glycoprotein I (beta2-GP I), cryoglobulins, C3, and C4. Patients with infections were younger than AAV patients (p < 0.01). There was no difference in frequency of renal and skin lesions. AAV patients more frequently had pulmonary and nervous system manifestations (p < 0.01). Patients with infections more frequently had dual ANCA (high PR3, low MPO), aCL, anti-beta2-GP I, cryoglobulins, and hypocomplementemia (p < 0.001). Immunosuppressive therapy (IST) was used in five 17 patients who had persistently high ANCA, cryoglobulinemia, and hypocomplementemia. There was no difference in frequency of lethality and renal failure in the two study groups. In patients who are PR3- and/or MPO-ANCA positive, SBE and HCV infection should be excluded. Although similar in renal and skin manifestations in comparison to AAV, only patients with infections developed multiple serological abnormalities. In patients with infections, concomitant presence of ANCA, cryoglobulins, and hypocomplementemia was associated with severe glomerulonephritis. The serological profile should be repeated after specific antimicrobial or surgical therapy, since some cases might require IST.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20306213     DOI: 10.1007/s10067-010-1424-4

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  45 in total

1.  Contribution of immunofluorescence to the identification and characterization of anti-neutrophil cytoplasmic autoantibodies. The role of different fixatives.

Authors:  A Radice; M Vecchi; M B Bianchi; R A Sinico
Journal:  Clin Exp Rheumatol       Date:  2000 Nov-Dec       Impact factor: 4.473

2.  Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis.

Authors:  J S Li; D J Sexton; N Mick; R Nettles; V G Fowler; T Ryan; T Bashore; G R Corey
Journal:  Clin Infect Dis       Date:  2000-04-03       Impact factor: 9.079

3.  Mixed cryoglobulinaemia, glomerulonephritis, and ANCA: essential cryoglobulinaemic vasculitis or ANCA-associated vasculitis?

Authors:  P Lamprecht; W H Schmitt; W L Gross
Journal:  Nephrol Dial Transplant       Date:  1998-01       Impact factor: 5.992

4.  Patients hospitalized because of small vessel vasculitides with renal involvement in the period 1975-95: organ involvement, anti-neutrophil cytoplasmic antibodies patterns, seasonal attack rates and fluctuation of annual frequencies.

Authors:  M Tidman; R Olander; C Svalander; D Danielsson
Journal:  J Intern Med       Date:  1998-08       Impact factor: 8.989

5.  Peripheral B-cell CD5 expansion and CD81 overexpression and their association with disease severity and autoimmune markers in chronic hepatitis C virus infection.

Authors:  E Zuckerman; G Slobodin; A Kessel; E Sabo; D Yeshurun; K Halas; E Toubi
Journal:  Clin Exp Immunol       Date:  2002-05       Impact factor: 4.330

6.  Glomerular immune deposits are associated with increased proteinuria in patients with ANCA-associated crescentic nephritis.

Authors:  Irmgard Neumann; Heinz Regele; Renate Kain; Rainer Birck; Franz Thomas Meisl
Journal:  Nephrol Dial Transplant       Date:  2003-03       Impact factor: 5.992

7.  Propylthiouracil-associated antineutrophil cytoplasmic autoantibody-positive vasculitis: retrospective study of 19 cases.

Authors:  Yong-Xi Chen; Hai-Jin Yu; Li-Yan Ni; Wen Zhang; Yao-Wen Xu; Hong Ren; Xiao-Nong Chen; Xiang-Ling Wang; Xiao Li; Xiao-Xia Pan; Wei-Ming Wang; Nan Chen
Journal:  J Rheumatol       Date:  2007-11-01       Impact factor: 4.666

Review 8.  Clinical and immunological features of drug-induced and infection-induced proteinase 3-antineutrophil cytoplasmic antibodies and myeloperoxidase-antineutrophil cytoplasmic antibodies and vasculitis.

Authors:  Elena Csernok; Peter Lamprecht; Wolfgang L Gross
Journal:  Curr Opin Rheumatol       Date:  2010-01       Impact factor: 5.006

9.  Antineutrophil cytoplasmic antibody (ANCA)-associated systemic vasculitis after immunisation with bacterial proteins.

Authors:  J Savige; L Nassis; T Cooper; B Paspaliaris; P Martinello; D MacGregor
Journal:  Clin Exp Rheumatol       Date:  2002 Nov-Dec       Impact factor: 4.473

10.  CpG oligodeoxynucleotide stimulates production of anti-neutrophil cytoplasmic antibodies in ANCA associated vasculitis.

Authors:  Plinio R Hurtado; Lisa Jeffs; Jodie Nitschke; Mittal Patel; Ghafar Sarvestani; John Cassidy; Pravin Hissaria; David Gillis; Chen Au Peh
Journal:  BMC Immunol       Date:  2008-07-14       Impact factor: 3.615

View more
  38 in total

1.  Life-threatening ANCA-positive vasculitis associated with rickettsial infection.

Authors:  Ashley Nickerson; Paul Ellis Marik
Journal:  BMJ Case Rep       Date:  2012-05-30

2.  Induction of proteinase 3-anti-neutrophil cytoplasmic autoantibodies by proteinase 3-homologous bacterial protease in mice.

Authors:  Yong Chul Kim; Yun Sik Choi; Jehan Alam; Yun-Ji Kim; Keum Jin Baek; Jaemoon Koh; Yeong Wook Song; Doo-Hyun Chung; Youngnim Choi
Journal:  Immunol Res       Date:  2016-04       Impact factor: 2.829

Review 3.  Useful biomarkers for assessment of hepatitis C virus infection-associated autoimmune disorders.

Authors:  Deng-Ho Yang; Ling-Jun Ho; Jenn-Haung Lai
Journal:  World J Gastroenterol       Date:  2014-03-21       Impact factor: 5.742

4.  IgM ANCA in healthy individuals and in patients with ANCA-associated vasculitis.

Authors:  L S Jeffs; C A Peh; A Nelson; P G Tan; E Davey; K Chappell; G B Perkins; P R Hurtado
Journal:  Immunol Res       Date:  2019-10       Impact factor: 2.829

Review 5.  Pathogenesis of ANCA-Associated Pulmonary Vasculitis.

Authors:  Marco A Alba; J Charles Jennette; Ronald J Falk
Journal:  Semin Respir Crit Care Med       Date:  2018-11-07       Impact factor: 3.119

6.  Renal-limited vasculitis with elevated levels of multiple antibodies.

Authors:  Noriaki Sato; Hideki Yokoi; Hirotaka Imamaki; Eiichiro Uchino; Kaoru Sakai; Takeshi Matsubara; Tatsuo Tsukamoto; Sachiko Minamiguchi; Motoko Yanagita
Journal:  CEN Case Rep       Date:  2017-03-03

7.  A case of mistaken identity: subacute bacterial endocarditis associated with p-antineutrophil cytoplasmic antibody.

Authors:  A M Riding; D P D'Cruz
Journal:  BMJ Case Rep       Date:  2010-12-14

Review 8.  Pathogenesis and treatment of ANCA-associated vasculitis-a role for complement.

Authors:  Damien Noone; Diane Hebert; Christoph Licht
Journal:  Pediatr Nephrol       Date:  2016-09-05       Impact factor: 3.714

Review 9.  Pulmonary vasculitis.

Authors:  Ana Casal; Juan Díaz-Garel; Tara Pereiro; María E Toubes; Jorge Ricoy; Luis Valdés
Journal:  J Thorac Dis       Date:  2018-09       Impact factor: 2.895

Review 10.  Autoimmunity, end organ damage, and the origin of autoantibodies and autoreactive T cells in systemic lupus erythematosus.

Authors:  Janet E Lewis; Shu Man Fu; Felicia Gaskin
Journal:  Discov Med       Date:  2013-02       Impact factor: 2.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.